As supplement use grows in the U.S., so are rates of toxic hepatitis
From 1995 through 2020, supplement-related liver failure requiring U.S. patients to be waitlisted for transplants increased eightfold, according to a study.
From 1995 through 2020, supplement-related liver failure requiring U.S. patients to be waitlisted for transplants increased eightfold, according to a study.
What's Your Reaction?
